THURSDAY, Feb. 2 (HealthDay News) — Sometimes, there’s nothing better than scratching an itch. And a new study suggests that where the itch resides is key to the pleasure derived from scratching.
The findings help improve understanding of itch and might even help folks battling itchy skin ailments, according to study author Dr. Gil Yosipovitch, a professor of dermatology at Wake Forest Baptist Medical Center in Winston-Salem, N.C.
FRIDAY, Nov. 25 (HealthDay News) — Patients hospitalized for autoimmune disorders, like rheumatoid arthritis or Crohn’s disease, may be at greater risk for a life-threatening pulmonary embolism, a clot in a main artery of the lung, a new study finds.
Reporting online Nov. 25 in The Lancet, researchers warned that steps should be taken to prevent this condition among patients admitted to the hospital for autoimmune diseases.
By Denise Mann
HealthDay Reporter
MONDAY, Nov. 21 (HealthDay News) — Many people with the skin disease psoriasis put a higher value on a treatment that suits their lifestyle than on out-of-pocket costs and side effects, a new German study finds.
As many as 7.5 million Americans have the chronic skin condition, according to the National Psoriasis Foundation. The most common type is plaque psoriasis, characterized by raised, red patches covered with a silvery white buildup of dead skin cells.
THURSDAY, Nov. 17 (HealthDay News) — Inflammation caused by psoriasis may trigger changes in a person’s cholesterol, including weakening the function of high-density lipoprotein (HDL), the “good” cholesterol, new research suggests.
The researchers said that, if confirmed, their findings could help explain why people with psoriasis — a chronic skin condition — are at greater risk for heart attack, stroke and cardiovascular death, especially if the psoriasis is moderate to severe.
By Serena Gordon
HealthDay Reporter
WEDNESDAY, Oct. 26 (HealthDay News) — An experimental psoriasis treatment performed significantly better than the commonly prescribed medication methotrexate in a new clinical trial.
The drug briakinumab reduced psoriasis symptoms by at least 75 percent in nearly 82 percent of those taking it, compared to just 40 percent of those on methotrexate. But serious side effects were more common among the briakinumab users.
THURSDAY, Oct. 13 (HealthDay News) — Nearly one in four Americans with the chronic skin condition known as psoriasis may also have undiagnosed psoriatic arthritis, according to a new study.
This is in addition to the 2 million people in the United States who have been diagnosed with the disease, a type of inflammatory arthritis that affects the joints and tendons and can lead to joint destruction and disability.
WEDNESDAY, Sept. 21 (HealthDay News) — How children are treated for psoriasis may depend on whether they see a pediatrician, dermatologist or internist, a new study suggests.
About 1 percent of children from birth to age 18 are affected by psoriasis, a skin condition that can lead to patches of itchy, flaky, dry skin.
TUESDAY, August 23, 2011 (Health.com) — For people with severe cases of psoriasis, the injectable drugs known as biologics can provide much-needed relief from the itchy, flaky skin lesions caused by the disorder.
These drugs are powerful, however, and they carry a small risk of potentially serious infections and other side effects. In addition, recent clinical trials have linked a newer subclass of biologics that includes the drugs ustekinumab (Stelara) and briakinumab to an increased risk of heart attack and stroke. Read More
By Maureen Salamon
HealthDay Reporter
TUESDAY, Aug. 23 (HealthDay News) — An extensive review of research investigating injectable drugs to treat psoriasis — an autoimmune disorder triggering itchy, red skin patches — indicates the medications are not linked to higher heart risks.
But, the study authors said a lack of complete information from drug makers impeded their ability to assess potential dangers noted in earlier research.
By Maureen Salamon
HealthDay Reporter
WEDNESDAY, July 20 (HealthDay News) — Psoriasis and eczema both cause red, scaly skin rashes, but the similarities between the two common, distressing conditions typically end there.
And now, examining patients suffering from both ailments (a very rare phenomenon), German scientists have teased out the opposing immune system responses that prompt skin flare-ups for both diseases.
| Text Size: |  |
|
